Last edition
News about
Dr Reddy's Labs gets DCGI nod to launch molnupiravir in India
Dr. Reddy's Laboratories Ltd announced that it has received Emergency Use Authorization from the Drugs Controller General of India (DCGI) to manufacture and market the oral anti-viral drug molnupiravir capsules 200 mg for the treatment of adult patients with Covid-19, with SpO2 >93% and who have high risk of progression of the disease including hospital
Sun Pharma to set up manufacturing facility in AP
Sun Pharmaceutical Industries Ltd will be setting up a manufacturing facility in Andhra Pradesh, Sun Pharma?s founder, Dilip Shangvi and his team met with the Chief Minister of Andhra Pradesh, Y S Jagan Mohan Reddy to discuss the progress of the pharmaceutical sector and the setting up an end-to-end manufacturing facility in the state
DCGI seeks more data from SII over its application seeking emergency authorisation for Covovax
The Drugs Controller General of India (DCGI) has raised queries and sought more data from Serum Institute of India (SII) over its application seeking emergency authorisation for COVID vaccine Covovax, official sources said yesterday
6th Nutrition and Wellness Awards 2021 felicitates nutraceutical brands
The sixth edition of the Nutrition and Wellness Awards 2021 held in Mumbai welcomed and felicitated nutraceutical brands whose innovation and out-of-the-box ideas set new trends in the nutraceutical industry and created a buzz
Healthcare major Apollo Hospitals Enterprises Ltd (AHEL) is expected to see its e-pharmacy business to gain around 14 per cent market share over the next five years, driven by the omni-channel model it is currently working on, according to a latest report from Motilal Oswal Financial Services Ltd (MOFSL)
Government approves PLI scheme to boost domestic API production: Dr Mansukh Mandaviya
With a view to attain self-reliance and reduce import dependence in critical APIs, the Centre has approved ?Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) In India
IAFM organizes conference to promote and spread awareness on functional medicines in India
The Indian Association of Functional Medicine, an independent body launched its first conference with the objective of promoting the usage of Functional medicines in our day to day lives and reducing the dependency on other medicines that act on the symptom and subside the overall problem in a person?s body than acting on the actual underlying problem
Novartis inks option, collaboration & licensing pact with BeiGene for TIGIT inhibitor ociperlimab
Novartis announced the signing of an option, collaboration and license agreement with BeiGene, Ltd. for ociperlimab (BGB-A1217), expanding the company?s research and development activities in immuno-oncology. Ociperlimab is a late-stage TIGIT inhibitor, a novel class of anti-cancer therapies that blocks the TIGIT protein receptor
Pharmexcil to organize seminar on "Reinvigorating India's Pharma Exports" on December 23 in Chennai
In an effort to revitalize pharmaceutical exporters of Tamil Nadu after the prolonged Covid shock, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) is organizing a one-day seminar on the subject ?Reinvigorating India?s Pharma Exports?, focusing latest pharmaceutical export policies and regulations
Piramal Pharma to invest minority stake in Yapan Bio
Piramal Pharma Limited (PPL) announced an investment of Rs. 101.77 crore in Yapan Bio Pvt Ltd of Hyderabad, India, augmenting the capabilities of its contract development and manufacturing organization (CDMO) business, Piramal Pharma Solutions (PPS). PPL holds 27.78% equity stake in the company as a result of this investment
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy